等待开盘 05-20 09:30:00 美东时间
-0.450
-1.61%
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
Small caps lead a mixed Wall Street session as Trump rejects Iran's peace response, sending crude back above $97, copper to a record and silver up 7%.
05-12 00:51
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
RBC Capital analyst Rishi Jaluria maintains Dropbox (NASDAQ:DBX) with a Outperform and raises the price target from $30 to $32.
05-09 00:42
Dropbox (NASDAQ:DBX) sees Q2 sales of $624.000 million-$627.000 million vs $620.562 million analyst estimate.
05-08 17:24
Dropbox (NASDAQ:DBX) raises FY2026 sales outlook from $2.485 billion-$2.500 billion to $2.497 billion-$2.512 billion vs $2.501 billion estimate.
05-08 17:24
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Dropbox业绩会实录,以下是Q1 2026财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** Q1营收6.29亿美元,同比增长0.8%;剔除FormSwift影响后同比增长2%,FormSwift对营收增长造成1.2个百分点的拖累。年度经常性收入(ARR)达25.6亿美元,同比增长0.3%,剔除FormSwift影响后同比增长1.3%。 **盈利能力:** 毛利率81.1%,同比下降1.8个百分点;非GAAP营业利润率40.1%,同比下降1.6个百分点,但超出38%的指引预期。净利润1.8亿美元,稀释每股收益0.76美元,较去年同期
05-08 12:15
华盛资讯5月8日讯,Dropbox, Inc. Class A公布2026财年Q1业绩,公司Q1营收6.30亿美元,同比增长0.8%,归母净利润1.15亿美元,同比下滑23.8%。
05-08 07:55
Dropbox shares are trading higher after the company reported better-than-expect...
05-08 04:05
Dropbox (NASDAQ:DBX) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.70 by 8.57 percent. This is a 8.57 percent increase over earnings of $0.70 per share from the same
05-08 04:04